Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2015, Article ID 970862, 7 pages
http://dx.doi.org/10.1155/2015/970862
Review Article

Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson’s Disease

Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria

Received 2 September 2015; Accepted 3 November 2015

Academic Editor: Antonio Pisani

Copyright © 2015 Atbin Djamshidian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Evenden, “Varieties of impulsivity,” Psychopharmacology, vol. 146, no. 4, pp. 348–361, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Weintraub, J. Koester, M. N. Potenza et al., “Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients,” Archives of Neurology, vol. 67, no. 5, pp. 589–595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. P. J. Garcia-Ruiz, J. C. Martinez Castrillo, A. Alonso-Canovas et al., “Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 85, no. 8, pp. 840–844, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Baumann-Vogel, P. O. Valko, G. Eisele, and C. R. Baumann, “Impulse control disorders in Parkinson's disease: don't set your mind at rest by self-assessments,” European Journal of Neurology, vol. 22, no. 4, pp. 603–609, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Ávila, X. Cardona, J. Bello, P. Maho, F. Sastre, and M. Martín-Baranera, “Impulse control disorders and punding in Parkinson's disease: the need for a structured interview,” Neurologia, vol. 26, no. 3, pp. 166–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. T. C. Napier, J.-C. Corvol, A. A. Grace et al., “Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease,” Movement Disorders, vol. 30, no. 2, pp. 141–149, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Voon, M. Sohr, A. E. Lang et al., “Impulse control disorders in Parkinson disease: a multicenter case—control study,” Annals of Neurology, vol. 69, no. 6, pp. 986–996, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. K. Scullin, A. B. Sollinger, J. Land et al., “Sleep and impulsivity in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 19, no. 11, pp. 991–994, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. S. O'Sullivan, C. M. Loane, A. D. Lawrence, A. H. Evans, P. Piccini, and A. J. Lees, “Sleep disturbance and impulsive-compulsive behaviours in Parkinson's disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 82, no. 6, pp. 620–622, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Pontone, J. R. Williams, S. S. Bassett, and L. Marsh, “Clinical features associated with impulse control disorders in Parkinson disease,” Neurology, vol. 67, no. 7, pp. 1258–1261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publishing, Washington, DC, USA, 5th edition, 2013.
  12. D. A. Gallagher, S. S. O'Sullivan, A. H. Evans, A. J. Lees, and A. Schrag, “Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series,” Movement Disorders, vol. 22, no. 12, pp. 1757–1763, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Djamshidian, F. Cardoso, D. Grosset, H. Bowden-Jones, and A. J. Lees, “Pathological gambling in Parkinson's disease-a review of the literature,” Movement Disorders, vol. 26, no. 11, pp. 1976–1984, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Raina, M. G. Cersosimo, and F. Micheli, “Zoophilia and impulse control disorder in a patient with Parkinson disease,” Journal of Neurology, vol. 259, no. 5, pp. 969–970, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Solla, A. Cannas, M. G. Marrosu, and F. Marrosu, “Dopaminergic-induced paraphilias associated with impulse control and related disorders in patients with Parkinson disease,” Journal of Neurology, vol. 259, no. 12, pp. 2752–2754, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Rylander, “Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs,” Psychiatria, Neurologia, Neurochirurgia, vol. 75, no. 3, pp. 203–212, 1972. View at Google Scholar
  17. J. H. Friedman, “Punding on levodopa,” Biological Psychiatry, vol. 36, no. 5, pp. 350–351, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. A. H. Evans, R. Katzenschlager, D. Paviour et al., “Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome,” Movement Disorders, vol. 19, no. 4, pp. 397–405, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. S. O'Sullivan, A. H. Evans, N. P. Quinn, A. D. Lawrence, and A. J. Lees, “Reckless generosity in Parkinson's disease,” Movement Disorders, vol. 25, no. 2, pp. 221–223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. S. O'Sullivan, A. Djamshidian, A. H. Evans, C. M. Loane, A. J. Lees, and A. D. Lawrence, “Excessive hoarding in Parkinson's disease,” Movement Disorders, vol. 25, no. 8, pp. 1026–1033, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. H. Friedman and V. Chang, “Crack cocaine use due to dopamine agonist therapy in Parkinson disease,” Neurology, vol. 80, no. 24, pp. 2269–2270, 2013. View at Publisher · View at Google Scholar
  22. K. L. Bienfait, M. Menza, M. H. Mark, and R. D. Dobkin, “Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists,” Journal of Clinical Neuroscience, vol. 17, no. 4, pp. 539–540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. H. Evans, A. D. Lawrence, J. Potts, S. Appel, and A. J. Lees, “Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease,” Neurology, vol. 65, no. 10, pp. 1570–1574, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Giovannoni, J. D. O'Sullivan, K. Turner, A. J. Manson, and A. J. L. Lees, “Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies,” Journal of Neurology Neurosurgery and Psychiatry, vol. 68, no. 4, pp. 423–428, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Weintraub, S. Hoops, J. A. Shea et al., “Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease,” Movement Disorders, vol. 24, no. 10, pp. 1461–1467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. A. Rabinak and M. J. Nirenberg, “Dopamine agonist withdrawal syndrome in parkinson disease,” Archives of Neurology, vol. 67, no. 1, pp. 58–63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. S. O'Sullivan, K. Wu, M. Politis et al., “Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours,” Brain, vol. 134, no. 4, pp. 969–978, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. T. D. L. Steeves, J. Miyasaki, M. Zurowski et al., “Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study,” Brain, vol. 132, no. 5, pp. 1376–1385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. B. B. Averbeck, S. S. O'Sullivan, and A. Djamshidian, “Impulsive and compulsive behaviors in Parkinson's disease,” Annual Review of Clinical Psychology, vol. 10, pp. 553–580, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Dagher and T. W. Robbins, “Personality, addiction, dopamine: insights from Parkinson's disease,” Neuron, vol. 61, no. 4, pp. 502–510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. D. Berke and S. E. Hyman, “Addiction, dopamine, and the molecular mechanisms of memory,” Neuron, vol. 25, no. 3, pp. 515–532, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. D. F. Muresanu, A. Stan, and A. Buzoianu, “Neuroplasticity and impulse control disorders,” Journal of the Neurological Sciences, vol. 316, no. 1-2, pp. 15–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Biundo, L. Weis, S. Facchini et al., “Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease,” Movement Disorders, vol. 30, no. 5, pp. 688–695, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Ye, A. Hammer, E. Camara, and T. F. Münte, “Pramipexole modulates the neural network of reward anticipation,” Human Brain Mapping, vol. 32, no. 5, pp. 800–811, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. N. J. Ray, J. M. Miyasaki, M. Zurowski et al., “Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study,” Neurobiology of Disease, vol. 48, no. 3, pp. 519–525, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Djamshidian, S. S. O'Sullivan, Y. Sanotsky et al., “Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?” Movement Disorders, vol. 27, no. 9, pp. 1137–1145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Djamshidian, A. Jha, S. S. O'Sullivan et al., “Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease,” Movement Disorders, vol. 25, no. 13, pp. 2203–2210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Voon, J. Gao, C. Brezing et al., “Dopamine agonists and risk: impulse control disorders in Parkinson's disease,” Brain, vol. 134, no. 5, pp. 1438–1446, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J.-Y. Lee, E. K. Lee, S. S. Park et al., “Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease,” Movement Disorders, vol. 24, no. 12, pp. 1803–1810, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. D. E. Comings, L. Ferry, S. Bradshaw-Robinson, R. Burchette, C. Chiu, and D. Muhleman, “The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking,” Pharmacogenetics, vol. 6, no. 1, pp. 73–79, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. D. S. S. Lobo, R. P. Souza, R. P. Tong et al., “Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects,” Biological Psychology, vol. 85, no. 1, pp. 33–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Foltynie, S. G. J. Lewis, T. E. Goldberg et al., “The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease,” Journal of Neurology, vol. 252, no. 7, pp. 833–838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Cormier, J. Muellner, and J.-C. Corvol, “Genetics of impulse control disorders in Parkinson's disease,” Journal of Neural Transmission, vol. 120, no. 4, pp. 665–671, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Voon, P.-O. Fernagut, J. Wickens et al., “Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders,” The Lancet Neurology, vol. 8, no. 12, pp. 1140–1149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. C. Rodriguez-Oroz, J. López-Azcárate, D. Garcia-Garcia et al., “Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease,” Brain, vol. 134, no. 1, pp. 36–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Parhami, A. Siani, R. J. Rosenthal, S. Lin, M. Collard, and T. W. Fong, “Sleep and gambling severity in a community sample of gamblers,” Journal of Addictive Diseases, vol. 31, no. 1, pp. 67–79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Manev and T. Uz, “Clock genes: influencing and being influenced by psychoactive drugs,” Trends in Pharmacological Sciences, vol. 27, no. 4, pp. 186–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. P. K. Parekh, A. R. Ozburn, and C. A. McClung, “Circadian clock genes: effects on dopamine, reward and addiction,” Alcohol, vol. 49, no. 4, pp. 341–349, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Falcón and C. A. McClung, “A role for the circadian genes in drug addiction,” Neuropharmacology, vol. 56, supplement 1, pp. 91–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Abarca, U. Albrecht, and R. Spanagel, “Cocaine sensitization and reward are under the influence of circadian genes and rhythm,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 13, pp. 9026–9030, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. S. N. Archer and H. Oster, “How sleep and wakefulness influence circadian rhythmicity: effects of insufficient and mistimed sleep on the animal and human transcriptome,” Journal of Sleep Research, vol. 24, no. 5, pp. 476–493, 2015. View at Publisher · View at Google Scholar
  52. S.-S. Yoo, N. Gujar, P. Hu, F. A. Jolesz, and M. P. Walker, “The human emotional brain without sleep—a prefrontal amygdala disconnect,” Current Biology, vol. 17, no. 20, pp. R877–R878, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. W. D. S. Killgore, E. T. Kahn-Greene, E. L. Lipizzi, R. A. Newman, G. H. Kamimori, and T. J. Balkin, “Sleep deprivation reduces perceived emotional intelligence and constructive thinking skills,” Sleep Medicine, vol. 9, no. 5, pp. 517–526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. W. D. S. Killgore, T. J. Balkin, and N. J. Wesensten, “Impaired decision making following 49 h of sleep deprivation,” Journal of Sleep Research, vol. 15, no. 1, pp. 7–13, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. N. Gujar, S.-S. Yoo, P. Hu, and M. P. Walker, “Sleep deprivation amplifies reactivity of brain reward networks, biasing the appraisal of positive emotional experiences,” The Journal of Neuroscience, vol. 31, no. 12, pp. 4466–4474, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. J. L. Ireland and V. Culpin, “The relationship between sleeping problems and aggression, anger, and impulsivity in a population of juvenile and young offenders,” Journal of Adolescent Health, vol. 38, no. 6, pp. 649–655, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Kamphuis, D.-J. Dijk, M. Spreen, and M. Lancel, “The relation between poor sleep, impulsivity and aggression in forensic psychiatric patients,” Physiology and Behavior, vol. 123, pp. 168–173, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. R. B. Postuma, J.-F. Gagnon, and J. Y. Montplaisir, “REM sleep behavior disorder: from dreams to neurodegeneration,” Neurobiology of Disease, vol. 46, no. 3, pp. 553–558, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. J.-F. Gagnon, M.-A. Bédard, M. L. Fantini et al., “REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease,” Neurology, vol. 59, no. 4, pp. 585–589, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Sixel-Döring, E. Trautmann, B. Mollenhauer, and C. Trenkwalder, “Associated factors for REM sleep behavior disorder in Parkinson disease,” Neurology, vol. 77, no. 11, pp. 1048–1054, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Mahlknecht, A. Iranzo, B. Högl et al., “Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD,” Neurology, vol. 84, no. 7, pp. 654–658, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. M. L. Fantini, L. Macedo, M. Zibetti et al., “Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, no. 2, pp. 174–179, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. E. Kim, B. S. Jeon, H.-J. Yang et al., “REM sleep behavior disorder: association with motor complications and impulse control disorders in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 20, no. 10, pp. 1081–1084, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Bayard, Y. Dauvilliers, H. Yu et al., “Impulse control disorder and rapid eye movement sleep behavior disorder in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 20, no. 12, pp. 1411–1414, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. W. Poewe and B. Högl, “Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease,” Neurology, vol. 63, no. 8, supplement 3, pp. S12–S16, 2004. View at Google Scholar · View at Scopus
  66. C. M. Peralta, B. Frauscher, K. Seppi et al., “Restless legs syndrome in Parkinson's disease,” Movement Disorders, vol. 24, no. 14, pp. 2076–2080, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Muntean, F. Sixel-Döring, and C. Trenkwalder, “Serum ferritin levels in Parkinson's disease patients with and without restless legs syndrome,” Movement Disorders Clinical Practice, vol. 2, no. 3, pp. 249–252, 2015. View at Publisher · View at Google Scholar
  68. M. D. Gjerstad, O. B. Tysnes, and J. P. Larsen, “Increased risk of leg motor restlessness but not RLS in early Parkinson disease,” Neurology, vol. 77, no. 22, pp. 1941–1946, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. D. García-Borreguero, R. P. Allen, H. Benes et al., “Augmentation as a treatment complication of restless legs syndrome: concept and management,” Movement Disorders, vol. 22, supplement 18, pp. S476–S484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Högl, D. García-Borreguero, R. Kohnen et al., “Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study,” Journal of Neurology, vol. 257, no. 2, pp. 230–237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. V. Voon, A. Schoerling, S. Wenzel et al., “Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome,” BMC Neurology, vol. 11, article 117, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Pondal, C. Marras, J. Miyasaki et al., “Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 2, pp. 130–135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Menza, R. D. Dobkin, H. Marin, and K. Bienfait, “Sleep disturbances in Parkinson's disease,” Movement Disorders, vol. 25, supplement 1, pp. S117–S122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. J. H. Friedman and R. P. Millman, “Sleep disturbances and Parkinson's disease,” CNS Spectrums, vol. 13, no. 3, supplement 4, pp. 12–17, 2008. View at Google Scholar · View at Scopus
  75. T. Morgenthaler, M. Kramer, C. Alessi et al., “Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine report,” Sleep, vol. 29, no. 11, pp. 1415–1419, 2006. View at Google Scholar · View at Scopus
  76. S. Rios Romenets, L. Creti, C. Fichten et al., “Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease—a randomized study,” Parkinsonism and Related Disorders, vol. 19, no. 7, pp. 670–675, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Videnovic and D. Golombek, “Circadian and sleep disorders in Parkinson's disease,” Experimental Neurology, vol. 243, pp. 45–56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. L. M. Trotti and D. L. Bliwise, “Treatment of the sleep disorders associated with Parkinson's disease,” Neurotherapeutics, vol. 11, no. 1, pp. 68–77, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Djamshidian and J. H. Friedman, “Anxiety and depression in Parkinson's disease,” Current Treatment Options in Neurology, vol. 16, no. 4, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. C. A. M. Medeiros, P. F. Carvalhedo De Bruin, L. A. Lopes, M. C. Magalhães, M. De Lourdes Seabra, and V. M. Sales De Bruin, “Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study,” Journal of Neurology, vol. 254, no. 4, pp. 459–464, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. T. A. Mestre, A. P. Strafella, T. Thomsen, V. Voon, and J. Miyasaki, “Diagnosis and treatment of impulse control disorders in patients with movement disorders,” Therapeutic Advances in Neurological Disorders, vol. 6, no. 3, pp. 175–188, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. C. Juri, P. Chaná, J. Tapia, C. Kunstmann, and T. Parrao, “Quetiapine for insomnia in Parkinson disease: results from an open-label trial,” Clinical Neuropharmacology, vol. 28, no. 4, pp. 185–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Rotondo, D. Bosco, M. Plastino, A. Consoli, and F. Bosco, “Clozapine for medication-related pathological gambling in Parkinson disease,” Movement Disorders, vol. 25, no. 12, pp. 1994–1995, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Hardwick, H. Ward, A. Hassan, J. Romrell, and M. S. Okun, “Clozapine as a potential treatment for refractory impulsive, compulsive, and punding behaviors in Parkinson's disease,” Neurocase, vol. 19, no. 6, pp. 587–591, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Hinze-Selch, J. Mullington, A. Orth, C. J. Lauer, and T. Pollmächer, “Effects of clozapine on sleep: a longitudinal study,” Biological Psychiatry, vol. 42, no. 4, pp. 260–266, 1997. View at Publisher · View at Google Scholar · View at Scopus